Evidence map›Paper›PMID 31160282›Full record

ArticleAntimicrobial agents and chemotherapy2019

Multiple Copies of

Laura Vinué, Mohamad R A Sater, Ian Herriott, Miriam H Huntley, George A Jacoby, David C Hooper

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laura VinuéMassachusetts General Hospital, Boston, Massachusetts, USA lvinue-santolalla@mgh.haravard.edu.
Mohamad R A SaterDay Zero Diagnostics, Boston, Massachusetts, USA.
Ian HerriottDay Zero Diagnostics, Boston, Massachusetts, USA.
Miriam H HuntleyDay Zero Diagnostics, Boston, Massachusetts, USA.
George A JacobyLahey Hospital and Medical Center, Burlington, Massachusetts, USA.
David C HooperMassachusetts General Hospital, Boston, Massachusetts, USA.
Zero to Three · USMassachusetts General Hospital · USLahey Medical Center · US

Funding

Plasmid-mediated Quinolone ResistanceR01AI057576 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HOOPER, DAVID C · 2004 to 2018
$5.3M
NIAID NIH HHS R01 AI057576
6 · The paper itself

Abstract

In a previous study, mutants with enhanced ciprofloxacin resistance (Cip

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli ProteinsMicrobial Sensitivity TestsPlasmidsQuinolonesAnti-Bacterial AgentsEscherichia coli ProteinsQuinolonesA/C2 plasmidciprofloxacinEscherichia coliISCR1qnrA1

Identifiers

PMID31160282
PMCPMC6658789
OpenAlexW2946907506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.